Buenos Aires ( CNN ) -- A medical group in Argentina is asking for more drug-testing regulations in the South American country after a officials fined pharmaceutical company GlaxoSmithKline for alleged irregularities in a pediatric pneumonia vaccine trial . The Argentinian Federation of Health Professionals accuses drug maker GlaxoSmithKline of misleading participants and pressuring poor families into joining a trial for the Synflorix vaccine , which the company says protects against bacterial pneumonia and meningitis . `` They recruited children in an irregular manner . ... They did not do what they were supposed to . They did not inform . There were not independent witnesses . They pressured the mothers of poor children , '' said Jorge Yabkowsky , the federation 's director . But GlaxoSmithKline , the world 's second largest pharmaceutical company , denies those accusations and says it will appeal a judge 's approval of Argentina 's National Administration of Medicine , Food and Medical Technology 's fining the company and two doctors a total of nearly $ 240,000 for irregularities in documentation of the trial . In a statement , GlaxoSmithKline said it conducts clinical studies all over the world , respecting laws and meeting the highest standards of ethics and quality . `` The ruling has to do with procedures , with the form of documenting procedures of the studies . ... None of the patients that were included in this study were included without their appropriate consent , '' said Rosana Felice , medical director of Glaxo Argentina . Felice said official investigations by Argentina 's drug administration , known as ANMAT , and ethics reviews have not turned up any irregularities in the vaccine 's safety . GlaxoSmithKline 's statement said there are no cases alleging fraud or corruption in the study . The deaths of 14 children who reportedly died after participating in the trials , have drawn widespread attention in Argentinian media . Their deaths are under investigation , but there has been no evidence linking deaths to the vaccine or irregularities in the studies . Felice said GlaxoSmithKline categorically denies that the vaccine caused the deaths . `` In no case was it related to the administration of the vaccine , and this has been sufficiently demonstrated , proven and evaluated by ANMAT , '' Felice said . But the health professional federation pointed to the children 's deaths in its call for increased regulations on drug testing . The trial included 24,000 children , Felice said , including 14,000 children in Argentina and 10,000 others in Colombia and Panama . The Synflorix vaccine has been approved by regulatory agencies in more than 85 countries , based on more than 40 clinical studies , GlaxoSmithKline said .
Argentina 's judicial administration has fined the company and two doctors nearly $ 500 . A medical group accused GlaxoSmithKline of misleading the judges . The drug company denies those accusations and says it will appeal the fine . It says there were no irregularities in consent or the vaccine 's development .